Watson Labs receives AP status for Metformin Hydrochloride ANDA076818
Watson Labs Inc. has received Abbreviated Approval (AP) for ANDA076818, a generic version of Metformin Hydrochloride, from the FDA. This approval confirms that Watson Labs has met the necessary regulatory standards for the product, which is positioned within the diabetes treatment market.